+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Addiction Disorders Drugs Market Research Reports

Narcotic Overdose - Pipeline Insight, 2024 - Product Thumbnail Image

Narcotic Overdose - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Substance (Drug) Abuse - Pipeline Insight, 2024 - Product Thumbnail Image

Substance (Drug) Abuse - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nicotine Addiction - Pipeline Insight, 2024 - Product Thumbnail Image

Nicotine Addiction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Alcohol Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
Opioid Withdrawal Syndrome- - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Withdrawal Syndrome- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Nociceptin receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Nociceptin receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Delta Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Delta Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Opioid mu receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid mu receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Opioid Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Opioid kappa receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid kappa receptor agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 67 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive. The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more